SCHEMBL3165737

SCHEMBL3165737

CC(=O)NCCNc1cc(NC(=O)C(=O)N2CCN(Cc3ccc(Cl)cc3)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ADORA2B P29275 3/20 0.45
▸ ADORA2A P29274 3/20 0.45
▸ ADORA1 P30542 3/20 0.45
▸ ADORA3 P0DMS8 2/20 0.45
▸ FAAH O00519 5/20 0.44
▸ CHRM1 P11229 1/20 0.42
▸ HTR2A P28223 1/20 0.42
▸ MCHR1 Q99705 1/20 0.42
▸ PHGDH O43175 2/20 0.42
▸ LMNA P02545 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ NLRP3 Q96P20 1/20 0.40
▸ CHRNA7 P36544 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3171345 0.95 ADORA2B (0.49) ADORA2BADORA2AADORA1ADORA3FAAH
SCHEMBL3162253 0.88 ALDH1A1 (0.52) ADORA2BADORA2AADORA1ADORA3POLB
SCHEMBL3173228 0.88 ADORA1 (0.47) ADORA2BADORA2AADORA1ADORA3LMNA
SCHEMBL3161055 0.87 KMT2A (0.51) FAAHMCHR1LMNAPOLBKMT2A
SCHEMBL3175769 0.86 ADORA2A (0.45) ADORA2BADORA2AADORA1ADORA3LMNA
SCHEMBL3170151 0.86 ADORA2B (0.56) ADORA2BADORA2AADORA1ADORA3FAAH
SCHEMBL3164833 0.86 ADORA2B (0.49) ADORA2BADORA2AADORA1ADORA3LMNA
SCHEMBL3165340 0.86 ADORA2B (0.49) ADORA2BADORA2AADORA1ADORA3LMNA
SCHEMBL3155892 0.86 ADORA2A (0.46) ADORA2BADORA2AADORA1ADORA3LMNA
SCHEMBL3162937 0.86 ADORA2A (0.46) ADORA2BADORA2AADORA1ADORA3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback